Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

13th Congress of the EADO

3 - 6 May 2017
Megaron Athens International Conference Centre, Athens, Greece
EADO conference highlights
Will Davies - Medical Reporter, ecancer
EADO conference highlights ( Will Davies - Medical Reporter, ecancer )
23 May 2017
Theory and application of electrochemotherapy
Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy
Theory and application of electrochemotherapy ( Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy )
23 May 2017
Intralesional T-VEC and combinations for melanoma
Prof Sanjiv Agarwala - St. Luke's Cancer Center, Easton, USA
Intralesional T-VEC and combinations for melanoma ( Prof Sanjiv Agarwala - St. Luke's Cancer Center, Easton, USA )
18 May 2017
Role of histologic regression in melanoma
Dr Simone Ribero - Università degli Studi di Torino, Turin, Italy
Role of histologic regression in melanoma ( Dr Simone Ribero - Università degli Studi di Torino, Turin, Italy )
18 May 2017
Molecular testing for targeted therapies
Prof Claus Garbe - University of Tübingen, Tübingen, Germany
Molecular testing for targeted therapies ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )
18 May 2017
Brain metastases: Gamma knife and new treatments
Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France
Brain metastases: Gamma knife and new treatments ( Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France )
18 May 2017
Essential regional control of skin cancers
Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy
Essential regional control of skin cancers ( Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy )
18 May 2017
Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma
Dr Christian Blank - Netherlands Cancer Institute, Amsterdam, The Netherlands
Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma ( Dr Christian Blank - Netherlands Cancer Institute, Amsterdam, The Netherlands )
18 May 2017
Circulating tumour cells in melanoma
Dr Evi Lianidou - University of Athens, Athens, Greece
Circulating tumour cells in melanoma ( Dr Evi Lianidou - University of Athens, Athens, Greece )
18 May 2017
Novel high risk genes of melanoma
Prof Nick Hayward - QIMR Berghofer, Brisbane, Australia
Novel high risk genes of melanoma ( Prof Nick Hayward - QIMR Berghofer, Brisbane, Australia )
18 May 2017
New insights in Merkel cell biology and treatment
Dr Paul Nghiem - University of Washington, Seattle, USA
New insights in Merkel cell biology and treatment ( Dr Paul Nghiem - University of Washington, Seattle, USA )
18 May 2017
Duration of checkpoint inhibitor therapy
Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Duration of checkpoint inhibitor therapy ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
17 May 2017
PD1/ CTLA4 : Upfront or sequentially?
Prof Christoph Höller - Medical University of Vienna, Vienna, Austria
PD1/ CTLA4 : Upfront or sequentially? ( Prof Christoph Höller - Medical University of Vienna, Vienna, Austria )
17 May 2017
Brain metastases: a role of conventional chemotherapy?
Dr Peter Mohr - Elbe Klinikum Buxtehude, Germany
Brain metastases: a role of conventional chemotherapy? ( Dr Peter Mohr - Elbe Klinikum Buxtehude, Germany )
17 May 2017
New imaging approaches for the diagnosis of melanoma and skin cancer
Dr Josep Malvehy - University Hospital Clinic of Barcelona, Barcelona, Spain
New imaging approaches for the diagnosis of melanoma and skin cancer ( Dr Josep Malvehy - University Hospital Clinic of Barcelona, Barcelona, Spain )
17 May 2017